IP Verse

Method And Compositions For Inducing Differentiation Of Myeloid Derived Suppressor Cell To Treat Cancer And Infectious Diseases

Patent No. EP3209691 (titled "Method And Compositions For Inducing Differentiation Of Myeloid Derived Suppressor Cell To Treat Cancer And Infectious Diseases") was filed by OSE Immunotherapeutics on Oct 21, 2015. The application was issued on Jul 15, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BYONDISApr 15, 2021T HOEN VAN DER HOOGT
BYONDISApr 15, 2021VAN GENT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3209691

OSE IMMUNOTHERAPEUTICS
Application Number
EP15794641A
Filing Date
Oct 21, 2015
Status
Revoked
Oct 7, 2025
Publication Date
Jul 15, 2020
External Links
Slate, Register , Google Patents